THE WORKING VISIT OF THE DELEGATION OF THE GOVERNMENT OF KRASNOYARSK KRAI TO THE PRODUCTION FACILITY OF PJSC "KRASFARMA".
22.05.2024
THE WORKING VISIT OF THE DELEGATION OF THE GOVERNMENT OF KRASNOYARSK KRAI TO THE PRODUCTION FACILITY OF PJSC "KRASFARMA".
On May 22, 2024, a delegation from the Government of Krasnoyarsk Krai visited the PJSC "Krasfarma" enterprise on a working visit. The delegation included the Deputy Chairman of the Government of Krasnoyarsk Krai, Alexey Mikhailovich Medvedev, and the Minister of Health of Krasnoyarsk Krai, Natalia Stanislavovna Govorushkina. During the visit, the guests toured the plant's production facilities, visited the new fully equipped workshops, modern warehouse complex, modern life support systems of the plant, and the central laboratory.
The delegation representatives met with Olga Rashchupkina, Deputy General Director of PJSC "Krasfarma" for Production and Development, who provided detailed information on the stages of the plant's modernization, plans for further expanding production capacities, and plant development.
"Cooperation with the Government of Krasnoyarsk Krai, as well as with other regions of the Russian Federation, opens up new opportunities for interaction and broad prospects for our enterprise. For PJSC 'Krasfarma,' this could become a valuable source of new cooperation in the future development of the production base," said the owner of PJSC "Krasfarma," Ilya Yurievich Shpurov.
The delegation members highly appreciated the results of PJSC "Krasfarma's" global production modernization efforts and the significant expansion of the product range, as well as the technological capabilities of the plant, noting the competitiveness of the produced medicines and the long-established high quality.
At the final meeting, the parties discussed key issues related to development, personnel policy, production expansion, and potential cooperation within the framework of trade and industrial cooperation between PJSC "Krasfarma" and the business community of Krasnoyarsk Krai. Special attention was drawn to the innovative activities of the Krasnoyarsk pharmaceutical enterprise. In particular, projects related to the development, testing, and implementation of advanced treatments for hematological, rheumatological, and oncological diseases were discussed, involving scientific and clinical bases of Krasnoyarsk Krai. Medium-term plans were set for the most important direction of import substitution policy in the Russian pharmaceutical industry – the production of active pharmaceutical ingredients, with emphasis on the fact that PJSC "Krasfarma" has unique competencies and experience in producing raw materials for pharmaceutical products. As emphasized by Alexey Mikhailovich Medvedev, Deputy Chairman of the Government of Krasnoyarsk Krai, the success of the company's development plans, which encompass not only business issues but also a significant contribution to the social and economic welfare of the region, depends on mutual interest in joint work. Natalia Stanislavovna Govorushkina highlighted the high value of the import substitution program implemented by PJSC "Krasfarma," a strategic enterprise of Krasnoyarsk Krai, for ensuring uninterrupted supply of essential and vital medicines to healthcare institutions at both the regional and federal levels.
The delegation representatives met with Olga Rashchupkina, Deputy General Director of PJSC "Krasfarma" for Production and Development, who provided detailed information on the stages of the plant's modernization, plans for further expanding production capacities, and plant development.
"Cooperation with the Government of Krasnoyarsk Krai, as well as with other regions of the Russian Federation, opens up new opportunities for interaction and broad prospects for our enterprise. For PJSC 'Krasfarma,' this could become a valuable source of new cooperation in the future development of the production base," said the owner of PJSC "Krasfarma," Ilya Yurievich Shpurov.
The delegation members highly appreciated the results of PJSC "Krasfarma's" global production modernization efforts and the significant expansion of the product range, as well as the technological capabilities of the plant, noting the competitiveness of the produced medicines and the long-established high quality.
At the final meeting, the parties discussed key issues related to development, personnel policy, production expansion, and potential cooperation within the framework of trade and industrial cooperation between PJSC "Krasfarma" and the business community of Krasnoyarsk Krai. Special attention was drawn to the innovative activities of the Krasnoyarsk pharmaceutical enterprise. In particular, projects related to the development, testing, and implementation of advanced treatments for hematological, rheumatological, and oncological diseases were discussed, involving scientific and clinical bases of Krasnoyarsk Krai. Medium-term plans were set for the most important direction of import substitution policy in the Russian pharmaceutical industry – the production of active pharmaceutical ingredients, with emphasis on the fact that PJSC "Krasfarma" has unique competencies and experience in producing raw materials for pharmaceutical products. As emphasized by Alexey Mikhailovich Medvedev, Deputy Chairman of the Government of Krasnoyarsk Krai, the success of the company's development plans, which encompass not only business issues but also a significant contribution to the social and economic welfare of the region, depends on mutual interest in joint work. Natalia Stanislavovna Govorushkina highlighted the high value of the import substitution program implemented by PJSC "Krasfarma," a strategic enterprise of Krasnoyarsk Krai, for ensuring uninterrupted supply of essential and vital medicines to healthcare institutions at both the regional and federal levels.
